ZEB1 and breast carcinoma: Knockdown of ZEB1 in breast cancer, non-small cell lung carcinoma, and osteosarcoma cell lines leads to an increase in the sensitivity to radiotherapy while its ectopic expression in cell models of breast cancer decreases the sensitivity [83,84,85].